Browsing Category
Corona Virus
Covid patients relieved of symptoms in 24 hrs after taking antibody cocktail
Fifty Covid-19 patients who received single-dose monoclonal antibodies cocktail drug (casirivimab and imdevimab) were relieved of their symptoms within 24 hours of the therapy given at the AIG Hospitals in Hyderabad. "Preliminary analysis…
Scientists discover Covid’s link to life threatening blood clots
A team of scientists has identified how and why some Covid-19 patients can develop life-threatening blood clots. The study, led by researchers at the Royal College of Surgeons in Ireland (RCSI), found the balance between a molecule that…
Vietnam’s success on vaccine front to help it steer clear of old foe China
Vietnam has started the final stage phase III trials of its domestically developed coronavirus vaccine candidate that the country expects to roll out for mass use by the end of the year, according to a NikkeiAsia report from Hanoi.…
Supply of Covaxin to govt at Rs 150/dose not sustainable: Bharat Biotech
The supply price of Covaxin to the government of India at Rs 150 a dose is a non-competitive price and clearly not sustainable in the long run. Hence a higher price in private markets is required to offset part of the costs, Bharat Biotech…
Pfizer, AstraZeneca Covid jabs highly effective against Delta variant
Two doses of Pfizer and AstraZeneca's Covid-19 vaccines are highly effective against hospitalisation from the Delta (B16172) variant, according to new analysis from Public Health England (PHE). The analysis suggests that the Pfizer-BioNTech…
2-DG effective against all Covid variants, says study
The 2-deoxy-D-glucose (2-DG) developed by the Defence Research and Development organisation (DRDO) for the coronavirus treatment, effectively inhibits the SARS-CoV-2 multiplication and works against all variants of Covid-19, says a research…
SII partner Novavax’s Covid-19 shot 90% effective
US-based biotechnology company Novavax's protein-based vaccine has shown overall 90 per cent efficacy against Covid-19, results of Phase-3 trials have shown. The vaccine NVX-CoV2373 is already being locally manufactured by the company's…
Iran announces emergency use of domestic Covid vax
Iranian Health Minister Saeed Namaki has announced the emergency use of a domestic vaccine for Covid-19. The emergency use of COVIran Barakat financed by the Barakat Foundation has been authorised, Namaki said at a conference in the central…
AstraZeneca jab authorised for all age-groups, says EMA
AstraZeneca's Covid-19 vaccine remains authorised for all populations, European Medicines Agency (EMA) has said.The clarification camme after Italian newspaper La Stampa earlier quoted Marco Cavaleri, head of the EMA's vaccine strategy,…
Delhi AIIMS to begin Covaxin trial on children from Tuesday
The All India Institute of Medical Sciences (AIIMS) is learnt to have started screening of children aged 6-12 years for the clinical trials of India's first indigenously developed Covid-19 vaccine, Bharat Biotech's Covaxin.Sources said that…